TIDMSN.

RNS Number : 9220L

Smith & Nephew Plc

18 May 2022

SMITH & NEPHEW PLC

18 May 2022

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

On 17 May 2022, Smith & Nephew plc (the "Company") received notification of the following transactions as detailed below.

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------------ 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------------ 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------------ 
 Details of the transaction(s): section to be repeated for (i) 
  each type of instrument; (ii) each type of transaction; (iii) 
  each date; and (iv) each place where transactions have been conducted 
 Description of the          Smith & Nephew plc SPON ADR American Depositary 
  financial instrument,       Shares (ADS) 
  type of instrument 
                            ------------------------------------------------ 
 Identification code         ISIN: US83175M2052 
                            ------------------------------------------------ 
 Nature of the transaction   PDMR is a participant of the Company's Employee 
                              Stock Purchase Plan, which on 12 May 2022 
                              purchased American Depository Shares through 
                              the Company's Dividend Re-Investment Plan 
                              following the 2021 final dividend payment 
                              on 11 May 2022. 
                            ------------------------------------------------ 
 Date of Transaction         2022 - 05 - 12 
                            ------------------------------------------------ 
 Place of Transaction        New York Stock Exchange 
                            ------------------------------------------------ 
 
 
                                                                                           Total Ordinary 
                                                                                            Share Holding 
                                                                        Total Ordinary      as a % of 
                                                                         Share Holding      the Company's 
                                                                         following          ISC following 
 Name                   Director    Price                Aggregated      the transaction    the transaction 
  (Position)             / PDMR      ($)      Volume      information    *                  * 
 Bradley Cannon 
  (President                                                            99,528.87527 
  Orthopaedics,                                                          (including 
  Sports Medicine                                        N/A Single      2,759.85329 
  & ENT)                PDMR        29.7199   41.34469    Transaction    in ADS')          0.01124% 
                       ----------  --------  ---------  -------------  -----------------  ----------------- 
                                                                        2,350.90991 
 Alison Parkes                                                           (including 
  ( Chief Compliance                                     N/A Single      406.33079 
  Officer)              PDMR        29.7199   6.08717     Transaction    in ADS')          0.00027% 
                       ----------  --------  ---------  -------------  -----------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFIFEDEFITLIF

(END) Dow Jones Newswires

May 18, 2022 04:02 ET (08:02 GMT)

Smith & Nephew (LSE:SN.)
Graphique Historique de l'Action
De Juil 2022 à Août 2022 Plus de graphiques de la Bourse Smith & Nephew
Smith & Nephew (LSE:SN.)
Graphique Historique de l'Action
De Août 2021 à Août 2022 Plus de graphiques de la Bourse Smith & Nephew